The first volunteer questions
Human studies conducted 2019–2020
What do you ask the first volunteers?
Now the room is human-sized. Subject One offers a confident thumbs-up; Doctide offers a sampling schedule. “You may tell us everything you notice.” He lowers the thumb and picks up a pencil. The small details suddenly seem important.
What changes here
Early studies focused on exposure and tolerability. Gastrointestinal effects became part of the record, alongside the hoped-for benefits. [2]
Read the study details & dates
Single-exposure safety and pharmacology
An early human study in Singapore examined safety, tolerability and pharmacokinetics. The approximately six-day half-life helped support further development. This was an early research checkpoint, not a promise of treatment benefit. [1]
Repeated exposure in type 2 diabetes
A Phase 1b study enrolled 72 adults with type 2 diabetes and compared LY3437943 with dulaglutide and placebo. Gastrointestinal events were the most frequently reported adverse events. [2] [3]
What this does not establish
Subject One dramatizes the questions researchers were asking; he is not the actual first recipient. The dates refer to real studies, while his scene is newly written fiction.
Original sources
- Cell Metabolism discovery and first-human report
- Urva et al., Phase 1b primary publication
- Lilly study record and dates
Sources reviewed 2026-10-11. Study and publication dates are stated separately where known.
Subject One is fictional. Separate studies, species and populations are not a single patient’s experience. How to read the story